CDX2 serves as a Wnt signaling inhibitor and is frequently methylated in lung cancer.

Authors:
Liu X; Zhang X; Zhan Q; Brock MV; Herman JG and 1 more

Journal:
Cancer Biol Ther

Publication Year: 2012

DOI:
10.4161/cbt.21344

PMCID:
PMC3469472

PMID:
22892849

Journal Information

Full Title: Cancer Biol Ther

Abbreviation: Cancer Biol Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Therapeutics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure of Potential Conflicts of Interest No potential conflicts of interest were disclosed."

Evidence found in paper:

"We are very grateful to Prof. Youyong Lu for providing us the pEGFP-CDX2 and pcDNA-CDX2 vectors. This work was supported by grants from the National Basic Research Program (973 program no. 2012CB934002, 2010CB912802, 2009CB521801), National HighTechnology R&D Program of China (863 program no. SS2012AA020821, SS2012AA02A203, SS2012AA02A209), National Key Scientific instrument Special Programme of China (grant no. 2011YQ03013405) and National Science Foundation of China (grant no. 81121004, 81071953, 81161120432)"

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025